PRTN3 and rheumatoid arthritis: has been demonstrated to be enriched in stool samples of pre-RA subjects (i.e., ACPA/RF-positive and/or suggestive RA signs/symptoms) in comparison with asymptomatic autoantibody-negative first-degree relatives of RA patients (93).